| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 02/02/2006 | CA2575601A1 Methods for producing compositions comprising hyperpolarized 13c-pyruvate |
| 02/02/2006 | CA2575473A1 Radicals and their use as paramagnetic agents in a dnp process |
| 02/01/2006 | EP1621077A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/01/2006 | EP1620564A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 02/01/2006 | EP1619948A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands |
| 02/01/2006 | CN1729191A Pyrazoloquinolines with immunomodulating activity |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992187 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | CA2150806C Antiallergic triazolobenzazepine derivatives |
| 01/25/2006 | EP1618112A1 Heterocyclic mchr1 antagonists |
| 01/25/2006 | EP1618109A2 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists |
| 01/25/2006 | EP1618108A2 Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosine receptor antagonists |
| 01/25/2006 | CN1726603A Charge transport compositions and electronic devices made with such compositions |
| 01/25/2006 | CN1726205A 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 01/25/2006 | CN1724539A Purification method of catharanthine and vincristine |
| 01/25/2006 | CN1724538A Method of chromatography preparing high purity catharanthine sulphate by continuous medium pressure column |
| 01/19/2006 | WO2006007491A1 Mitotic kinesin inhibitors |
| 01/19/2006 | US20060014774 1-allyl ergot alkaloid derivatives, methods for producing the same and the use thereof for preventing and treating migraine |
| 01/19/2006 | US20060014750 Pharmaceutical compositions for the treatment of CNS and other disorders |
| 01/19/2006 | US20060011907 Compounds containing 3,4-methylenedioxythiophene units |
| 01/19/2006 | CA2571807A1 Mitotic kinesin inhibitors |
| 01/18/2006 | EP1616871A1 Porphyrin compound containing biotinyl group and use thereof |
| 01/18/2006 | EP1615930A2 Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagonists |
| 01/18/2006 | EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 01/17/2006 | CA2300069C Naphthalimidobenzamide derivatives |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1613612A2 Bioreductively-activated prodrugs |
| 01/11/2006 | EP1613322A2 Aminoquinoline compounds |
| 01/11/2006 | EP1613307A2 M sb 3 /sb muscarinic acetylcholine receptor antagonists |
| 01/11/2006 | CN1720332A Substrates for O6-alkylguanine-DNA alkyltransferase |
| 01/11/2006 | CN1720248A Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/10/2006 | US6984462 Organic electroluminescent devices using double-spiro organic compounds |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/10/2006 | CA2381513C Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/05/2006 | WO2006001511A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/05/2006 | WO2005100352A8 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
| 01/05/2006 | WO2005085259A3 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 01/05/2006 | WO2004091504A3 Substituted quinobenzoxazine analogs |
| 01/05/2006 | US20060004053 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003063 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 01/05/2006 | CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/04/2006 | EP1611207A1 Fluorescent diketopyrrolopyrroles |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1210714A4 High density non-volatile memory device |
| 01/04/2006 | CN1234709C Biporphin metal coordination compound with bridge linking face-face structure and its use |
| 01/04/2006 | CN1234708C Novel imidazotriazinones and the use thereof |
| 01/03/2006 | CA2185350C Acridone-derived bisintercalators as chemotherapeutic agents |
| 12/29/2005 | WO2005123745A1 Tricyclic compounds |
| 12/29/2005 | WO2005062882A3 Rifamycin analogs and uses thereof |
| 12/29/2005 | WO2005055939A3 Vinca derivatives |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288294 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/28/2005 | EP1608664A1 Non-cross-linking pyrrolo (2,1-c] (1,4]benzodiazepines as potential antitumour agents and process thereof |
| 12/28/2005 | EP1608663A1 Pyrrolo (2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof |
| 12/28/2005 | EP1129089B1 Spiro-indolines as y5 receptor antagonists |
| 12/22/2005 | WO2005121147A1 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 12/22/2005 | WO2005058231A3 Rifamycin analogs and uses thereof |
| 12/22/2005 | US20050282852 Preventive and therapeutic medicament for gastroesophageal reflux disease |
| 12/22/2005 | US20050282814 Vasculostatic agents and methods of use thereof |
| 12/22/2005 | US20050282813 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile |
| 12/21/2005 | EP1605938A2 Antibacterial agents |
| 12/21/2005 | EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function |
| 12/21/2005 | EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 12/21/2005 | EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 12/21/2005 | CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity |
| 12/20/2005 | US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 12/20/2005 | US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 12/15/2005 | WO2005118777A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 12/15/2005 | WO2005118583A1 2, 5-dihydro-pyrazolo`4, 3-c!quinolin-4-ones as chk-1 inhibitors |
| 12/15/2005 | WO2005117868A1 Tetrahydrocarboline antiviral agents |
| 12/15/2005 | WO2005071096A3 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample |
| 12/15/2005 | US20050277662 such as: 1-(2, 4-difluorobenzyl) -N-hydroxy-3-(morpholin-4-ylmethyl)-1H-pyrrolo[2,3-c]pyridine-5-carboxamide; acquired immunodeficiency syndrome ("AIDS"), and AIDS related complex ("ARC") |
| 12/15/2005 | US20050277661 Inhibitors of the HIV integrase enzyme |
| 12/15/2005 | CA2568415A1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 12/14/2005 | EP1604993A1 Inhibitors |
| 12/14/2005 | EP1604021A2 Methods for identifying enzyme inhibitors and protein kinases |
| 12/14/2005 | EP1603917A1 Immunomodulating heterocyclic compounds |
| 12/14/2005 | CN1708499A Purine compounds and use thereof as cannabinoid receptor ligands |
| 12/14/2005 | CN1231470C N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as polymerisation in hibitors |
| 12/08/2005 | WO2005116037A1 Purine derivative |
| 12/08/2005 | WO2005116034A1 Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 12/08/2005 | US20050272799 Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 12/08/2005 | US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 12/08/2005 | US20050272745 Novel piperidine and piperazine derivatives |
| 12/08/2005 | CA2568056A1 Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 12/08/2005 | CA2566863A1 Purine derivative |
| 12/07/2005 | EP1601677A1 Spiro-substituted pyrrolopyrimidines |
| 12/07/2005 | EP1601676A2 Fused imidazoles as transforming growth factor (tgf) inhibitors |
| 12/07/2005 | EP1379528A4 Pyrazolopyrimidines as therapeutic agents |
| 12/07/2005 | EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 12/01/2005 | WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use |
| 12/01/2005 | US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |